Denali Therapeutics Inc. DNLI Business Segments
| Q4 '26 | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | ||
|---|---|---|---|---|---|---|
| Total collaboration revenue by Product | ||||||
| Milestone Payment | $2.5M0.0% | $2.5M0.0% | $2.5M0.0% | $2.5M0.0% | $2.5M0.0% | |
| Milestone Triggered | $25M0.0% | $25M0.0% | $25M0.0% | $25M0.0% | $25M— | |
| Option Fee Payment | $2.5M+100% | $2.5M+100% | $2.5M+100% | $2.5M+100% | $1.25M0.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Denali Therapeutics Inc. break its business down?
- Denali Therapeutics Inc. (DNLI) reports total collaboration revenue by product across 3 parts — Milestone Payment, Milestone Triggered and Option Fee Payment. Each is extracted from the segment footnotes and tracked over time.
- Where does Denali Therapeutics Inc.'s segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Denali Therapeutics Inc.'s SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.